Michael J Allen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael J Allen

Showing results (91-100 of 118) with videos related to

Pageof 12

Sort By:

FEBS Letters|October 9, 2013

Functional and structural characterisation of a viral cytochrome b5Emma L Reid, Karen D Weynberg, John Love, et al.

Scientific Reports|November 21, 2024

Vulnerability of Arctic Ocean microbial eukaryotes to sea ice lossVictoria L N Jackson, Thomas Grevesse, Estelle S Kilias, et al.

Journal of Bacteriology|August 14, 2012

Genome sequence of Stenotrophomonas maltophilia PML168, which displays Baeyer-Villiger monooxygenase activityMichael J Allen, Karen Tait, Martin Mühling, et al.

Cancer Treatment Reviews|November 10, 2021

Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studiesNicholas Meti, Deirdre Kelly, Michael J Allen, et al.

Scientific Reports|May 23, 2015

Swirl Flow Bioreactor coupled with Cu-alginate beads: A system for the eradication of Coliform and Escherichia coli from biological effluentsSov Atkinson, Simon F Thomas, Paul Goddard, et al.

Journal of Medicinal Chemistry|October 28, 2005

2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokineticsAlan D Borthwick, Dave E Davies, Anne M Exall, et al.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 31, 2007

Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the ratGerald P McCafferty, Mark A Pullen, Charlene Wu, et al.

International Journal of Biometeorology|July 21, 2017

Supporting sustainability initiatives through biometeorology education and trainingMichael J Allen, Jennifer Vanos, David M Hondula, et al.

Bioorganic & Medicinal Chemistry Letters|May 7, 2002

Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivativesPaul G Wyatt, Michael J Allen, Josie Chilcott, et al.

Bioorganic & Medicinal Chemistry Letters|May 3, 2005

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SARPaul G Wyatt, Michael J Allen, Alan D Borthwick, et al.

Pageof 12

Search research articles

Showing results (91-100 of 118) with videos related to

Sort By:

Pageof 12

FEBS Letters|October 9, 2013

Functional and structural characterisation of a viral cytochrome b5Emma L Reid, Karen D Weynberg, John Love, et al.

Scientific Reports|November 21, 2024

Vulnerability of Arctic Ocean microbial eukaryotes to sea ice lossVictoria L N Jackson, Thomas Grevesse, Estelle S Kilias, et al.

Journal of Bacteriology|August 14, 2012

Genome sequence of Stenotrophomonas maltophilia PML168, which displays Baeyer-Villiger monooxygenase activityMichael J Allen, Karen Tait, Martin Mühling, et al.

Cancer Treatment Reviews|November 10, 2021

Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studiesNicholas Meti, Deirdre Kelly, Michael J Allen, et al.

Scientific Reports|May 23, 2015

Swirl Flow Bioreactor coupled with Cu-alginate beads: A system for the eradication of Coliform and Escherichia coli from biological effluentsSov Atkinson, Simon F Thomas, Paul Goddard, et al.

Journal of Medicinal Chemistry|October 28, 2005

2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokineticsAlan D Borthwick, Dave E Davies, Anne M Exall, et al.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 31, 2007

Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the ratGerald P McCafferty, Mark A Pullen, Charlene Wu, et al.

International Journal of Biometeorology|July 21, 2017

Supporting sustainability initiatives through biometeorology education and trainingMichael J Allen, Jennifer Vanos, David M Hondula, et al.

Bioorganic & Medicinal Chemistry Letters|May 7, 2002

Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivativesPaul G Wyatt, Michael J Allen, Josie Chilcott, et al.

Bioorganic & Medicinal Chemistry Letters|May 3, 2005

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SARPaul G Wyatt, Michael J Allen, Alan D Borthwick, et al.

Pageof 12